Search results
Kirsten Axelsen: Affordable access to weight loss drugs needed (Opinion)
The Charleston Gazette· 3 days agoSen. Bernie Sanders, I-Vt., is getting a piece of the attention being paid to weight loss drugs. Unsurprisingly, these medicines have gotten a lot of notice; losing weight and keeping it off ...
Fight Denied Medicare Claims: Find the Best Appeal Path
TheStreet.com· 3 days agoDiscover the right appeal path to combat denied Medicare claims. Jae Oh explains the best ways to get coverage approved. Approval to receive coverage for treatment under one's ...
California Attorney General Bonta Urges Supreme Court to Uphold States’ Authority to Regulate...
Sierra Sun Times· 7 days agoOAKLAND, CA – California Attorney General Rob Bonta on Wednesday joined a bipartisan coalition of 32...
Santa Claus concerned about the surging cost of weight-loss drugs: He's not the only one
Worcester Telegram & Gazette via Yahoo News· 2 days agoMedicare ever covered these drugs across the board. The scenario comes from the Health Policy...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 6 days agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
Final Section 1557 Rules: Highlights for Health Plan Sponsors | JD Supra
JD Supra· 4 days agoThe new rules apply to certain group health plans, as well as many health care providers. The nondiscrimination rules apply to employer-sponsored group health plans that receive funding from ...
Letter: We need alternatives to opioids
Bangor Daily News· 3 days agoAs a retired millworker, I have witnessed the devastating impact of the opioid crisis on mill towns throughout Maine and communities around the entire...
JD Supra: The ACA 1557 Final Regulations: Plans and Plan Sponsors as Covered Entities
JD Supra· 3 days agoIn a recent On the Subject (available here), we reported on the impact of the final rule (final rule) interpreting Section 1557 of the Affordable Care Act (ACA) on self-funded group health plans ...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 6 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat ...
Gateway - Quartz
Quartz· 6 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...
